Stephanie Meek

A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanoma

Abhijit Ray, Matthew A. Williams, Stephanie Meek et al. · Oncotarget · 2016 · 75 citations · Full text

Medicine, Dermatology, Oncology +12

Performance of the IBIS/Tyrer‐Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative

Allison W. Kurian, Elisha Hughes, Timothy Simmons et al. · Cancer · 2021 · 55 citations · Full text

Medicine, Oncology, Preventive Medicine +17

The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial

Peter Dubsky, Christian F. Singer, Daniel Egle et al. · European Journal of Cancer · 2020 · 52 citations · Full text

Medicine, Endocrinology, Oncology +16

High risk of breast cancer in women with biallelic pathogenic variants in CHEK2

Irene Rainville, Shanell Hatcher, Eric T. Rosenthal et al. · Breast Cancer Research and Treatment · 2020 · 51 citations · Full text

Medicine, Genetics, Oncology +17

Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing

Elisha Hughes, Placede Tshiaba, Susanne Wagner et al. · JCO Precision Oncology · 2021 · 34 citations · Full text

Life Sciences, Genetics, Oncology +17